Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients
NCT00686868
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Arthritis, Rheumatoid
Interventions
OTHER:
placebo
DRUG:
ofatumumab
Sponsor
GlaxoSmithKline